Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 7.00352954 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.00352954 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.84154413 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.84154413 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.15719418 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.83456753 |
7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.83348718 |
8 | glyoxylate metabolic process (GO:0046487) | 5.60799947 |
9 | kynurenine metabolic process (GO:0070189) | 5.55540969 |
10 | sulfur amino acid catabolic process (GO:0000098) | 5.47505302 |
11 | tryptophan catabolic process (GO:0006569) | 5.45720512 |
12 | indole-containing compound catabolic process (GO:0042436) | 5.45720512 |
13 | indolalkylamine catabolic process (GO:0046218) | 5.45720512 |
14 | cysteine metabolic process (GO:0006534) | 5.41799849 |
15 | negative regulation of fibrinolysis (GO:0051918) | 5.41598301 |
16 | bile acid biosynthetic process (GO:0006699) | 5.41580870 |
17 | urea cycle (GO:0000050) | 5.37270283 |
18 | urea metabolic process (GO:0019627) | 5.37270283 |
19 | tryptophan metabolic process (GO:0006568) | 5.11661963 |
20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.05687351 |
21 | protein carboxylation (GO:0018214) | 5.05687351 |
22 | lysine catabolic process (GO:0006554) | 5.00026122 |
23 | lysine metabolic process (GO:0006553) | 5.00026122 |
24 | complement activation, alternative pathway (GO:0006957) | 4.99316630 |
25 | regulation of fibrinolysis (GO:0051917) | 4.98291347 |
26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.97957667 |
27 | serine family amino acid catabolic process (GO:0009071) | 4.97698284 |
28 | regulation of protein activation cascade (GO:2000257) | 4.92686381 |
29 | nitrogen cycle metabolic process (GO:0071941) | 4.91227799 |
30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.89682061 |
31 | homocysteine metabolic process (GO:0050667) | 4.70836654 |
32 | bile acid metabolic process (GO:0008206) | 4.66679208 |
33 | regulation of complement activation (GO:0030449) | 4.63265558 |
34 | regulation of triglyceride catabolic process (GO:0010896) | 4.60619560 |
35 | amino-acid betaine metabolic process (GO:0006577) | 4.52604279 |
36 | glycine metabolic process (GO:0006544) | 4.48634908 |
37 | aromatic amino acid family metabolic process (GO:0009072) | 4.48408281 |
38 | alpha-amino acid catabolic process (GO:1901606) | 4.48039635 |
39 | plasma lipoprotein particle clearance (GO:0034381) | 4.38994574 |
40 | reverse cholesterol transport (GO:0043691) | 4.38373064 |
41 | negative regulation of sterol transport (GO:0032372) | 4.38100162 |
42 | negative regulation of cholesterol transport (GO:0032375) | 4.38100162 |
43 | acylglycerol homeostasis (GO:0055090) | 4.37873944 |
44 | triglyceride homeostasis (GO:0070328) | 4.37873944 |
45 | cellular ketone body metabolic process (GO:0046950) | 4.37253134 |
46 | regulation of cholesterol esterification (GO:0010872) | 4.31915672 |
47 | tyrosine metabolic process (GO:0006570) | 4.30686700 |
48 | serine family amino acid metabolic process (GO:0009069) | 4.28525662 |
49 | protein-lipid complex remodeling (GO:0034368) | 4.25972399 |
50 | macromolecular complex remodeling (GO:0034367) | 4.25972399 |
51 | plasma lipoprotein particle remodeling (GO:0034369) | 4.25972399 |
52 | coenzyme catabolic process (GO:0009109) | 4.24573310 |
53 | cellular modified amino acid catabolic process (GO:0042219) | 4.23770136 |
54 | glutamate metabolic process (GO:0006536) | 4.23416026 |
55 | cellular amino acid catabolic process (GO:0009063) | 4.22688018 |
56 | serine family amino acid biosynthetic process (GO:0009070) | 4.13426709 |
57 | ethanol oxidation (GO:0006069) | 4.13203935 |
58 | regulation of cholesterol homeostasis (GO:2000188) | 4.09170024 |
59 | sodium ion export (GO:0071436) | 4.07860701 |
60 | acetyl-CoA metabolic process (GO:0006084) | 4.07772633 |
61 | imidazole-containing compound metabolic process (GO:0052803) | 4.01942348 |
62 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.97700151 |
63 | phospholipid efflux (GO:0033700) | 3.97624126 |
64 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.92717196 |
65 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.89143471 |
66 | 2-oxoglutarate metabolic process (GO:0006103) | 3.87023347 |
67 | bile acid and bile salt transport (GO:0015721) | 3.85267957 |
68 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.84766132 |
69 | positive regulation of lipid catabolic process (GO:0050996) | 3.83039529 |
70 | valine metabolic process (GO:0006573) | 3.80731676 |
71 | ketone body metabolic process (GO:1902224) | 3.78054440 |
72 | cholesterol efflux (GO:0033344) | 3.75223884 |
73 | indolalkylamine metabolic process (GO:0006586) | 3.73663443 |
74 | benzene-containing compound metabolic process (GO:0042537) | 3.73154862 |
75 | cellular glucuronidation (GO:0052695) | 3.72386988 |
76 | short-chain fatty acid metabolic process (GO:0046459) | 3.71848380 |
77 | * organic acid catabolic process (GO:0016054) | 3.70817907 |
78 | * carboxylic acid catabolic process (GO:0046395) | 3.70817907 |
79 | aspartate family amino acid catabolic process (GO:0009068) | 3.68762551 |
80 | plasma lipoprotein particle assembly (GO:0034377) | 3.68472344 |
81 | arginine metabolic process (GO:0006525) | 3.66266646 |
82 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.63495609 |
83 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.62525754 |
84 | fibrinolysis (GO:0042730) | 3.61730503 |
85 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.60321827 |
86 | drug catabolic process (GO:0042737) | 3.57943436 |
87 | phospholipid homeostasis (GO:0055091) | 3.55358002 |
88 | cholesterol homeostasis (GO:0042632) | 3.54066013 |
89 | cellular biogenic amine catabolic process (GO:0042402) | 3.54062661 |
90 | amine catabolic process (GO:0009310) | 3.54062661 |
91 | * fatty acid beta-oxidation (GO:0006635) | 3.52974876 |
92 | epoxygenase P450 pathway (GO:0019373) | 3.52794150 |
93 | adherens junction assembly (GO:0034333) | 3.51710519 |
94 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.51077828 |
95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.51077828 |
96 | sterol homeostasis (GO:0055092) | 3.50459914 |
97 | negative regulation of lipase activity (GO:0060192) | 3.50426886 |
98 | * fatty acid oxidation (GO:0019395) | 3.49748734 |
99 | cytolysis (GO:0019835) | 3.48204880 |
100 | focal adhesion assembly (GO:0048041) | 3.47157096 |
101 | cell-substrate adherens junction assembly (GO:0007045) | 3.47157096 |
102 | * monocarboxylic acid catabolic process (GO:0072329) | 3.45790488 |
103 | cofactor catabolic process (GO:0051187) | 3.45016488 |
104 | protein-lipid complex assembly (GO:0065005) | 3.43191823 |
105 | * lipid oxidation (GO:0034440) | 3.41680123 |
106 | * fatty acid catabolic process (GO:0009062) | 3.41135317 |
107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.37280674 |
108 | carnitine metabolic process (GO:0009437) | 3.36633770 |
109 | cellular potassium ion homeostasis (GO:0030007) | 3.34991112 |
110 | cerebellar granule cell differentiation (GO:0021707) | 3.33641254 |
111 | protein retention in ER lumen (GO:0006621) | 3.29137539 |
112 | layer formation in cerebral cortex (GO:0021819) | 3.27470902 |
113 | proline biosynthetic process (GO:0006561) | 3.23466599 |
114 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.20344508 |
115 | creatine metabolic process (GO:0006600) | 3.17957577 |
116 | positive regulation of synapse maturation (GO:0090129) | 3.15592854 |
117 | regulation of early endosome to late endosome transport (GO:2000641) | 3.13435925 |
118 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.08543004 |
119 | COPI coating of Golgi vesicle (GO:0048205) | 3.06419628 |
120 | Golgi transport vesicle coating (GO:0048200) | 3.06419628 |
121 | glutamate secretion (GO:0014047) | 3.02656704 |
122 | NADH metabolic process (GO:0006734) | 3.00743585 |
123 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.97644614 |
124 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.95701860 |
125 | regulation of ARF protein signal transduction (GO:0032012) | 2.94583041 |
126 | protein localization to endosome (GO:0036010) | 2.90663296 |
127 | activation of Rac GTPase activity (GO:0032863) | 2.86427459 |
128 | negative regulation of cell size (GO:0045792) | 2.85131389 |
129 | apoptotic process involved in morphogenesis (GO:0060561) | 2.84271630 |
130 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.79661022 |
131 | protein targeting to plasma membrane (GO:0072661) | 2.77307698 |
132 | amino acid import (GO:0043090) | 2.72232840 |
133 | neuromuscular process controlling balance (GO:0050885) | 2.72227754 |
134 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.71779746 |
135 | peptidyl-lysine dimethylation (GO:0018027) | 2.71524856 |
136 | synaptic vesicle maturation (GO:0016188) | 2.70462526 |
137 | histone H3-K9 demethylation (GO:0033169) | 2.70023737 |
138 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.69436584 |
139 | regulation of translational fidelity (GO:0006450) | 2.68564438 |
140 | cell-substrate junction assembly (GO:0007044) | 2.66176972 |
141 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.62067159 |
142 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.60776764 |
143 | proline metabolic process (GO:0006560) | 2.59672747 |
144 | response to parathyroid hormone (GO:0071107) | 2.58198586 |
145 | protein complex localization (GO:0031503) | 2.55398459 |
146 | cell communication by electrical coupling (GO:0010644) | 2.54918221 |
147 | paraxial mesoderm development (GO:0048339) | 2.53386117 |
148 | mating behavior (GO:0007617) | 2.51025402 |
149 | negative regulation of catenin import into nucleus (GO:0035414) | 2.50653887 |
150 | synaptic vesicle exocytosis (GO:0016079) | 2.49995524 |
151 | maternal placenta development (GO:0001893) | 2.49508396 |
152 | cellular protein complex localization (GO:0034629) | 2.47764735 |
153 | gluconeogenesis (GO:0006094) | 2.45304428 |
154 | respiratory system process (GO:0003016) | 2.45202307 |
155 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.45187816 |
156 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.44340387 |
157 | mitochondrion transport along microtubule (GO:0047497) | 2.44340387 |
158 | locomotory exploration behavior (GO:0035641) | 2.44090338 |
159 | cell migration in hindbrain (GO:0021535) | 2.43513927 |
160 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.42342238 |
161 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.42226337 |
162 | mitotic chromosome condensation (GO:0007076) | 2.40579101 |
163 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.40249032 |
164 | activation of protein kinase A activity (GO:0034199) | 2.39465171 |
165 | cerebellar Purkinje cell layer development (GO:0021680) | 2.39172335 |
166 | mannose metabolic process (GO:0006013) | 2.39112364 |
167 | oxaloacetate metabolic process (GO:0006107) | 2.38979055 |
168 | response to mercury ion (GO:0046689) | 2.38904007 |
169 | activation of MAPKKK activity (GO:0000185) | 2.38684697 |
170 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.38665523 |
171 | basement membrane organization (GO:0071711) | 2.37466038 |
172 | glycolytic process (GO:0006096) | 2.34948582 |
173 | L-amino acid import (GO:0043092) | 2.33067593 |
174 | positive regulation of myotube differentiation (GO:0010831) | 2.31862146 |
175 | cell-cell junction maintenance (GO:0045217) | 2.30700118 |
176 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.30497499 |
177 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.29791502 |
178 | neuronal ion channel clustering (GO:0045161) | 2.29609350 |
179 | hexose biosynthetic process (GO:0019319) | 2.28965519 |
180 | mRNA stabilization (GO:0048255) | 2.28384590 |
181 | RNA stabilization (GO:0043489) | 2.28384590 |
182 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.28375988 |
183 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.28222921 |
184 | cellular sodium ion homeostasis (GO:0006883) | 2.27794230 |
185 | semaphorin-plexin signaling pathway (GO:0071526) | 2.27594762 |
186 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.27454728 |
187 | negative regulation of fatty acid transport (GO:2000192) | 2.27163061 |
188 | positive regulation of glucose import (GO:0046326) | 2.26340900 |
189 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.26103502 |
190 | regulation of chromatin binding (GO:0035561) | 2.25119218 |
191 | peptidyl-proline hydroxylation (GO:0019511) | 2.23961822 |
192 | establishment of mitochondrion localization (GO:0051654) | 2.23955983 |
193 | cellular response to monoamine stimulus (GO:0071868) | 2.23251303 |
194 | cellular response to catecholamine stimulus (GO:0071870) | 2.23251303 |
195 | positive regulation of glucose transport (GO:0010828) | 2.23087541 |
196 | convergent extension (GO:0060026) | 2.22834957 |
197 | monosaccharide biosynthetic process (GO:0046364) | 2.22765724 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.76405713 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.77533921 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.21963379 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.90508240 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.47663787 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.77510527 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.31470002 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74904316 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.33622623 |
10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.84170491 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.81932048 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.71524209 |
13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.45501543 |
14 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.36584470 |
15 | KDM2B_26808549_Chip-Seq_K562_Human | 2.27993176 |
16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.11589375 |
17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0396901 |
18 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.99182389 |
19 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.98407474 |
20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.83705433 |
21 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.79592616 |
22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71490805 |
23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.68830461 |
24 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.66440269 |
25 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.65382777 |
26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.63608173 |
27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.60526028 |
28 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.57219384 |
29 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.57217996 |
30 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.57005643 |
31 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.56717660 |
32 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.51954366 |
33 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.49863288 |
34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.49471242 |
35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47718703 |
36 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.39327087 |
37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38971674 |
38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38927626 |
39 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38727685 |
40 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36588014 |
41 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.36024933 |
42 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.33595223 |
43 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33045516 |
44 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30229488 |
45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29699139 |
46 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28671920 |
47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28225792 |
48 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27986538 |
49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27309000 |
50 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26091873 |
51 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.25490760 |
52 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21098143 |
53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.19786662 |
54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.19786662 |
55 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.18315592 |
56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18202112 |
57 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.15451426 |
58 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.14225578 |
59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13268070 |
60 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12978531 |
61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12193054 |
62 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.11044282 |
63 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10428351 |
64 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10203780 |
65 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08118781 |
66 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08118781 |
67 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07344928 |
68 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05601589 |
69 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.05363804 |
70 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.04702232 |
71 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.03493356 |
72 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03205389 |
73 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.02344049 |
74 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02002067 |
75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99510235 |
76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98964598 |
77 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98479929 |
78 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.98068271 |
79 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.97708266 |
80 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96777469 |
81 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96458822 |
82 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.96398238 |
83 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.95389448 |
84 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95281027 |
85 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.93708085 |
86 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.92848657 |
87 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.92565576 |
88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92200988 |
89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87852244 |
90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87397414 |
91 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.86767053 |
92 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.83340824 |
93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80120593 |
94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79795092 |
95 | ATF3_27146783_Chip-Seq_COLON_Human | 0.79761755 |
96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79357414 |
97 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.79055494 |
98 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78887804 |
99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.76932420 |
100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74351736 |
101 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.73355004 |
102 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.71178018 |
103 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68380286 |
104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67340559 |
105 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.66475454 |
106 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.66335722 |
107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.65508209 |
108 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.65244185 |
109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.62417904 |
110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62414751 |
111 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.62381403 |
112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61948450 |
113 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.61941945 |
114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.61666541 |
115 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.61485512 |
116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.61123004 |
117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.60835827 |
118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60653423 |
119 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.59476312 |
120 | P68_20966046_ChIP-Seq_HELA_Human | 0.58502271 |
121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.58222177 |
122 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.58046004 |
123 | MYC_22102868_ChIP-Seq_BL_Human | 0.57868738 |
124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.57121275 |
125 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.56676638 |
126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.56490138 |
127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.56374777 |
128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.55213483 |
129 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.54863686 |
130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.54297167 |
131 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.54165037 |
132 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.53907459 |
133 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.53791673 |
134 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.53745550 |
135 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.53537566 |
136 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.53023084 |
137 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.52874593 |
138 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.51977426 |
139 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.51881236 |
140 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.51616286 |
141 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.51270172 |
142 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.51247924 |
143 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50930698 |
144 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.50083359 |
145 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.50017801 |
146 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.49757220 |
147 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.49720856 |
148 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49246453 |
149 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.49010594 |
150 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.48827585 |
151 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.48418838 |
152 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47862825 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.13605528 |
2 | MP0005360_urolithiasis | 7.22327963 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.90111407 |
4 | * MP0005365_abnormal_bile_salt | 5.89604486 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.47843831 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.22345321 |
7 | MP0010329_abnormal_lipoprotein_level | 3.69589295 |
8 | MP0003252_abnormal_bile_duct | 3.65888826 |
9 | MP0004859_abnormal_synaptic_plasticity | 3.46620983 |
10 | MP0009840_abnormal_foam_cell | 3.34755919 |
11 | MP0005083_abnormal_biliary_tract | 3.10026219 |
12 | MP0000751_myopathy | 3.04121133 |
13 | MP0002822_catalepsy | 2.84088990 |
14 | MP0005332_abnormal_amino_acid | 2.78672883 |
15 | MP0001666_abnormal_nutrient_absorption | 2.63325293 |
16 | MP0004858_abnormal_nervous_system | 2.57624694 |
17 | MP0003195_calcinosis | 2.37741717 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.30762437 |
19 | MP0000609_abnormal_liver_physiology | 2.23849759 |
20 | MP0002118_abnormal_lipid_homeostasis | 2.23585331 |
21 | MP0003705_abnormal_hypodermis_morpholog | 2.17883796 |
22 | MP0004270_analgesia | 2.16702737 |
23 | MP0001348_abnormal_lacrimal_gland | 2.15027019 |
24 | MP0004233_abnormal_muscle_weight | 2.07547459 |
25 | MP0005409_darkened_coat_color | 2.01990754 |
26 | MP0000566_synostosis | 2.00591746 |
27 | MP0004019_abnormal_vitamin_homeostasis | 2.00499256 |
28 | MP0005076_abnormal_cell_differentiation | 1.92796849 |
29 | MP0005319_abnormal_enzyme/_coenzyme | 1.91021074 |
30 | MP0000537_abnormal_urethra_morphology | 1.90242056 |
31 | * MP0000747_muscle_weakness | 1.89714475 |
32 | MP0005423_abnormal_somatic_nervous | 1.88623192 |
33 | MP0003868_abnormal_feces_composition | 1.88511852 |
34 | MP0000759_abnormal_skeletal_muscle | 1.87929298 |
35 | MP0000733_abnormal_muscle_development | 1.83964683 |
36 | MP0001849_ear_inflammation | 1.81851582 |
37 | MP0004087_abnormal_muscle_fiber | 1.80625591 |
38 | MP0003879_abnormal_hair_cell | 1.72939259 |
39 | MP0002138_abnormal_hepatobiliary_system | 1.70925037 |
40 | MP0002249_abnormal_larynx_morphology | 1.68110952 |
41 | MP0003123_paternal_imprinting | 1.65232417 |
42 | MP0005670_abnormal_white_adipose | 1.62628948 |
43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60006255 |
44 | MP0000749_muscle_degeneration | 1.53840875 |
45 | MP0004130_abnormal_muscle_cell | 1.46331419 |
46 | MP0001764_abnormal_homeostasis | 1.44661295 |
47 | MP0001346_abnormal_lacrimal_gland | 1.43023952 |
48 | MP0010030_abnormal_orbit_morphology | 1.40544114 |
49 | MP0000579_abnormal_nail_morphology | 1.39955050 |
50 | MP0000678_abnormal_parathyroid_gland | 1.39421601 |
51 | MP0009780_abnormal_chondrocyte_physiolo | 1.38277794 |
52 | MP0002877_abnormal_melanocyte_morpholog | 1.36723184 |
53 | MP0003634_abnormal_glial_cell | 1.34014457 |
54 | MP0008569_lethality_at_weaning | 1.32760562 |
55 | MP0000750_abnormal_muscle_regeneration | 1.32576136 |
56 | MP0009643_abnormal_urine_homeostasis | 1.32564565 |
57 | MP0003635_abnormal_synaptic_transmissio | 1.31115239 |
58 | MP0003091_abnormal_cell_migration | 1.30819168 |
59 | MP0002089_abnormal_postnatal_growth/wei | 1.28001180 |
60 | MP0003453_abnormal_keratinocyte_physiol | 1.27893089 |
61 | MP0010630_abnormal_cardiac_muscle | 1.27093560 |
62 | * MP0000598_abnormal_liver_morphology | 1.26139989 |
63 | MP0003011_delayed_dark_adaptation | 1.23973266 |
64 | MP0008260_abnormal_autophagy | 1.21634350 |
65 | MP0005257_abnormal_intraocular_pressure | 1.20508844 |
66 | MP0000604_amyloidosis | 1.20075089 |
67 | MP0003186_abnormal_redox_activity | 1.19954975 |
68 | MP0004036_abnormal_muscle_relaxation | 1.18840595 |
69 | MP0005666_abnormal_adipose_tissue | 1.18263796 |
70 | MP0002106_abnormal_muscle_physiology | 1.17662026 |
71 | MP0001730_embryonic_growth_arrest | 1.16710910 |
72 | MP0003656_abnormal_erythrocyte_physiolo | 1.16649374 |
73 | MP0010352_gastrointestinal_tract_polyps | 1.11715811 |
74 | MP0000462_abnormal_digestive_system | 1.10908710 |
75 | MP0003115_abnormal_respiratory_system | 1.10175010 |
76 | MP0005369_muscle_phenotype | 1.08649337 |
77 | MP0002108_abnormal_muscle_morphology | 1.08004422 |
78 | MP0002063_abnormal_learning/memory/cond | 1.07369520 |
79 | MP0005623_abnormal_meninges_morphology | 1.06795977 |
80 | MP0006138_congestive_heart_failure | 1.05638262 |
81 | MP0000762_abnormal_tongue_morphology | 1.04492763 |
82 | MP0002971_abnormal_brown_adipose | 1.03162042 |
83 | MP0003329_amyloid_beta_deposits | 0.97127179 |
84 | MP0000534_abnormal_ureter_morphology | 0.95717698 |
85 | MP0005451_abnormal_body_composition | 0.94904487 |
86 | * MP0002078_abnormal_glucose_homeostasis | 0.94684764 |
87 | MP0009763_increased_sensitivity_to | 0.93418745 |
88 | MP0002254_reproductive_system_inflammat | 0.90992578 |
89 | MP0005647_abnormal_sex_gland | 0.90203770 |
90 | MP0005334_abnormal_fat_pad | 0.90033521 |
91 | MP0003385_abnormal_body_wall | 0.88761565 |
92 | MP0005220_abnormal_exocrine_pancreas | 0.88393855 |
93 | MP0004782_abnormal_surfactant_physiolog | 0.87706377 |
94 | MP0009278_abnormal_bone_marrow | 0.86816934 |
95 | * MP0009642_abnormal_blood_homeostasis | 0.86752513 |
96 | MP0005636_abnormal_mineral_homeostasis | 0.86126845 |
97 | MP0005084_abnormal_gallbladder_morpholo | 0.85298330 |
98 | MP0002896_abnormal_bone_mineralization | 0.84726181 |
99 | MP0005535_abnormal_body_temperature | 0.84255651 |
100 | MP0000920_abnormal_myelination | 0.83051111 |
101 | MP0002064_seizures | 0.82392480 |
102 | MP0004185_abnormal_adipocyte_glucose | 0.81679304 |
103 | MP0000778_abnormal_nervous_system | 0.81472608 |
104 | MP0009697_abnormal_copulation | 0.80469074 |
105 | * MP0006036_abnormal_mitochondrial_physio | 0.78677392 |
106 | MP0005448_abnormal_energy_balance | 0.77277298 |
107 | MP0004811_abnormal_neuron_physiology | 0.76412140 |
108 | MP0001299_abnormal_eye_distance/ | 0.76333902 |
109 | MP0008438_abnormal_cutaneous_collagen | 0.75653303 |
110 | MP0005330_cardiomyopathy | 0.75635890 |
111 | MP0001502_abnormal_circadian_rhythm | 0.75057711 |
112 | MP0008469_abnormal_protein_level | 0.75043992 |
113 | MP0005376_homeostasis/metabolism_phenot | 0.74295488 |
114 | MP0009764_decreased_sensitivity_to | 0.74180877 |
115 | MP0000467_abnormal_esophagus_morphology | 0.73610206 |
116 | MP0010368_abnormal_lymphatic_system | 0.73578557 |
117 | MP0005375_adipose_tissue_phenotype | 0.72561610 |
118 | MP0000428_abnormal_craniofacial_morphol | 0.72326904 |
119 | MP0002332_abnormal_exercise_endurance | 0.72187546 |
120 | MP0000955_abnormal_spinal_cord | 0.70984606 |
121 | MP0009053_abnormal_anal_canal | 0.69703821 |
122 | MP0002837_dystrophic_cardiac_calcinosis | 0.69374471 |
123 | MP0005501_abnormal_skin_physiology | 0.68820405 |
124 | MP0005266_abnormal_metabolism | 0.68677584 |
125 | MP0005275_abnormal_skin_tensile | 0.68080133 |
126 | MP0002970_abnormal_white_adipose | 0.67962118 |
127 | MP0001756_abnormal_urination | 0.67833705 |
128 | MP0004510_myositis | 0.67717884 |
129 | * MP0003861_abnormal_nervous_system | 0.65957592 |
130 | MP0002009_preneoplasia | 0.65625691 |
131 | MP0004272_abnormal_basement_membrane | 0.65400318 |
132 | MP0009765_abnormal_xenobiotic_induced | 0.64886820 |
133 | MP0002080_prenatal_lethality | 0.64522859 |
134 | MP0002066_abnormal_motor_capabilities/c | 0.64222328 |
135 | MP0000350_abnormal_cell_proliferation | 0.63223434 |
136 | MP0001661_extended_life_span | 0.62094556 |
137 | MP0002876_abnormal_thyroid_physiology | 0.59833717 |
138 | MP0010234_abnormal_vibrissa_follicle | 0.59600218 |
139 | MP0000639_abnormal_adrenal_gland | 0.57190588 |
140 | MP0009115_abnormal_fat_cell | 0.57087393 |
141 | MP0003638_abnormal_response/metabolism_ | 0.55519851 |
142 | MP0003959_abnormal_lean_body | 0.55153393 |
143 | MP0003690_abnormal_glial_cell | 0.54950915 |
144 | MP0008961_abnormal_basal_metabolism | 0.53081669 |
145 | MP0002136_abnormal_kidney_physiology | 0.50847202 |
146 | MP0009672_abnormal_birth_weight | 0.50757591 |
147 | MP0002269_muscular_atrophy | 0.50550138 |
148 | MP0003953_abnormal_hormone_level | 0.50032378 |
149 | MP0005464_abnormal_platelet_physiology | 0.48505599 |
150 | MP0008873_increased_physiological_sensi | 0.47819760 |
151 | MP0005248_abnormal_Harderian_gland | 0.45366262 |
152 | MP0008874_decreased_physiological_sensi | 0.45257767 |
153 | MP0005023_abnormal_wound_healing | 0.43938626 |
154 | MP0002928_abnormal_bile_duct | 0.42838529 |
155 | MP0004264_abnormal_extraembryonic_tissu | 0.42680835 |
156 | MP0000013_abnormal_adipose_tissue | 0.41654308 |
157 | MP0002796_impaired_skin_barrier | 0.41572537 |
158 | MP0003075_altered_response_to | 0.40951686 |
159 | MP0005408_hypopigmentation | 0.40765790 |
160 | * MP0006035_abnormal_mitochondrial_morpho | 0.39782325 |
161 | MP0005395_other_phenotype | 0.39587185 |
162 | MP0001243_abnormal_dermal_layer | 0.39358015 |
163 | MP0001881_abnormal_mammary_gland | 0.38759473 |
164 | MP0003300_gastrointestinal_ulcer | 0.36824261 |
165 | MP0002168_other_aberrant_phenotype | 0.36631368 |
166 | MP0002060_abnormal_skin_morphology | 0.36254898 |
167 | MP0001915_intracranial_hemorrhage | 0.34725515 |
168 | MP0005452_abnormal_adipose_tissue | 0.33693882 |
169 | MP0001944_abnormal_pancreas_morphology | 0.33139319 |
170 | MP0000003_abnormal_adipose_tissue | 0.32939160 |
171 | MP0002909_abnormal_adrenal_gland | 0.32918857 |
172 | MP0005187_abnormal_penis_morphology | 0.31819191 |
173 | * MP0002135_abnormal_kidney_morphology | 0.31782994 |
174 | MP0003566_abnormal_cell_adhesion | 0.30143992 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.86642670 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.65825895 |
3 | Intrahepatic cholestasis (HP:0001406) | 6.54350660 |
4 | Xanthomatosis (HP:0000991) | 6.14804066 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.09917605 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.82746212 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.44870041 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.08771860 |
9 | Complement deficiency (HP:0004431) | 4.98174812 |
10 | Hyperammonemia (HP:0001987) | 4.65112258 |
11 | Ketosis (HP:0001946) | 4.54845946 |
12 | Hypolipoproteinemia (HP:0010981) | 4.50474919 |
13 | Hyperglycinemia (HP:0002154) | 4.38528880 |
14 | Epidermoid cyst (HP:0200040) | 4.37050207 |
15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.25221603 |
16 | Hyperglycinuria (HP:0003108) | 4.23254378 |
17 | Abnormality of glycine metabolism (HP:0010895) | 4.16352842 |
18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.16352842 |
19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.12510221 |
20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.06903586 |
21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.06094321 |
22 | Hypoalphalipoproteinemia (HP:0003233) | 4.04239338 |
23 | Hypoglycemic coma (HP:0001325) | 3.94721929 |
24 | Joint hemorrhage (HP:0005261) | 3.88699896 |
25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.84373024 |
26 | Exercise-induced myalgia (HP:0003738) | 3.79024117 |
27 | Abnormality of methionine metabolism (HP:0010901) | 3.75163793 |
28 | Abnormality of complement system (HP:0005339) | 3.70172240 |
29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.63128413 |
30 | Fat malabsorption (HP:0002630) | 3.59336287 |
31 | Hypercholesterolemia (HP:0003124) | 3.46311680 |
32 | Hyperacusis (HP:0010780) | 3.41548613 |
33 | Ketoacidosis (HP:0001993) | 3.35914311 |
34 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.32988880 |
35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.32917395 |
36 | Type 1 muscle fiber predominance (HP:0003803) | 3.22239597 |
37 | * Abnormality of fatty-acid metabolism (HP:0004359) | 3.17349923 |
38 | Obstructive sleep apnea (HP:0002870) | 3.14719721 |
39 | Muscle fiber inclusion bodies (HP:0100299) | 3.09581900 |
40 | Skin nodule (HP:0200036) | 3.05585780 |
41 | Spastic diplegia (HP:0001264) | 3.01600355 |
42 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.00691460 |
43 | Myopathic facies (HP:0002058) | 3.00573968 |
44 | Abnormality of serum amino acid levels (HP:0003112) | 2.98152967 |
45 | Hepatocellular carcinoma (HP:0001402) | 2.97834067 |
46 | Increased connective tissue (HP:0009025) | 2.97700588 |
47 | Hyperbilirubinemia (HP:0002904) | 2.97351475 |
48 | Abnormality of nucleobase metabolism (HP:0010932) | 2.96617571 |
49 | Cerebral inclusion bodies (HP:0100314) | 2.96038670 |
50 | Myocardial infarction (HP:0001658) | 2.94376355 |
51 | Protrusio acetabuli (HP:0003179) | 2.93985813 |
52 | Increased variability in muscle fiber diameter (HP:0003557) | 2.93157763 |
53 | Gout (HP:0001997) | 2.91963987 |
54 | Nemaline bodies (HP:0003798) | 2.89469986 |
55 | Insomnia (HP:0100785) | 2.87369294 |
56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.86521538 |
57 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.85483395 |
58 | Neurofibrillary tangles (HP:0002185) | 2.84761230 |
59 | * Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.80608152 |
60 | Delayed CNS myelination (HP:0002188) | 2.80374404 |
61 | Abnormality of purine metabolism (HP:0004352) | 2.78467658 |
62 | Distal lower limb amyotrophy (HP:0008944) | 2.77840661 |
63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.70841098 |
64 | Dicarboxylic aciduria (HP:0003215) | 2.70841098 |
65 | Metabolic acidosis (HP:0001942) | 2.65346302 |
66 | Neonatal onset (HP:0003623) | 2.60606633 |
67 | Calcaneovalgus deformity (HP:0001848) | 2.59899072 |
68 | Steatorrhea (HP:0002570) | 2.58732403 |
69 | Spontaneous abortion (HP:0005268) | 2.52484796 |
70 | Lower limb amyotrophy (HP:0007210) | 2.48703266 |
71 | Shallow orbits (HP:0000586) | 2.47563534 |
72 | Spinal rigidity (HP:0003306) | 2.45340302 |
73 | Achilles tendon contracture (HP:0001771) | 2.44948767 |
74 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.44668573 |
75 | Hypoglycemic seizures (HP:0002173) | 2.43142782 |
76 | Lethargy (HP:0001254) | 2.42322894 |
77 | Ankle clonus (HP:0011448) | 2.42145003 |
78 | Late onset (HP:0003584) | 2.39426339 |
79 | Exercise-induced muscle cramps (HP:0003710) | 2.39290390 |
80 | Supranuclear gaze palsy (HP:0000605) | 2.38834448 |
81 | Abnormality of the calcaneus (HP:0008364) | 2.38722433 |
82 | Dysmetric saccades (HP:0000641) | 2.35399194 |
83 | Cerebral aneurysm (HP:0004944) | 2.33949707 |
84 | Acanthocytosis (HP:0001927) | 2.33414993 |
85 | Systemic lupus erythematosus (HP:0002725) | 2.31727023 |
86 | Irritability (HP:0000737) | 2.30997727 |
87 | Cholelithiasis (HP:0001081) | 2.28979899 |
88 | Abnormal gallbladder physiology (HP:0012438) | 2.28857159 |
89 | Cholecystitis (HP:0001082) | 2.28857159 |
90 | Hypochromic microcytic anemia (HP:0004840) | 2.27552551 |
91 | Round ear (HP:0100830) | 2.26633001 |
92 | Hydroxyprolinuria (HP:0003080) | 2.26281777 |
93 | Abnormality of proline metabolism (HP:0010907) | 2.26281777 |
94 | Abnormal gallbladder morphology (HP:0012437) | 2.25923749 |
95 | Malnutrition (HP:0004395) | 2.25502546 |
96 | Distal lower limb muscle weakness (HP:0009053) | 2.20578326 |
97 | Difficulty climbing stairs (HP:0003551) | 2.20542160 |
98 | Sensorimotor neuropathy (HP:0007141) | 2.19027554 |
99 | Deformed tarsal bones (HP:0008119) | 2.15609263 |
100 | Distal upper limb amyotrophy (HP:0007149) | 2.15203404 |
101 | Upper limb amyotrophy (HP:0009129) | 2.15203404 |
102 | Hypercortisolism (HP:0001578) | 2.14053420 |
103 | Muscle stiffness (HP:0003552) | 2.13978036 |
104 | Mitral stenosis (HP:0001718) | 2.12620998 |
105 | Muscle fiber splitting (HP:0003555) | 2.12151606 |
106 | Ulnar bowing (HP:0003031) | 2.11764702 |
107 | Abnormality of the Achilles tendon (HP:0005109) | 2.11599746 |
108 | Hyporeflexia of lower limbs (HP:0002600) | 2.08377973 |
109 | EMG: myopathic abnormalities (HP:0003458) | 2.08130448 |
110 | Foot dorsiflexor weakness (HP:0009027) | 2.08099406 |
111 | Amyloidosis (HP:0011034) | 2.07855511 |
112 | Cerebral edema (HP:0002181) | 2.07614198 |
113 | Pancreatitis (HP:0001733) | 2.07336100 |
114 | Esophageal varix (HP:0002040) | 2.06633459 |
115 | Vertebral compression fractures (HP:0002953) | 2.06519119 |
116 | Myokymia (HP:0002411) | 2.04705494 |
117 | Vascular calcification (HP:0004934) | 2.03031233 |
118 | Vomiting (HP:0002013) | 2.00579939 |
119 | Back pain (HP:0003418) | 2.00176877 |
120 | Progressive muscle weakness (HP:0003323) | 1.99722551 |
121 | Hyperparathyroidism (HP:0000843) | 1.99466490 |
122 | * Turricephaly (HP:0000262) | 1.98148549 |
123 | Glomerulonephritis (HP:0000099) | 1.98095704 |
124 | Broad face (HP:0000283) | 1.97933171 |
125 | Overriding aorta (HP:0002623) | 1.97538689 |
126 | Hemorrhage of the eye (HP:0011885) | 1.97426506 |
127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96622761 |
128 | Increased purine levels (HP:0004368) | 1.96209355 |
129 | Hyperuricemia (HP:0002149) | 1.96209355 |
130 | Abnormality of the lower motor neuron (HP:0002366) | 1.96090742 |
131 | Generalized aminoaciduria (HP:0002909) | 1.95894558 |
132 | Menorrhagia (HP:0000132) | 1.95247950 |
133 | Difficulty running (HP:0009046) | 1.95020452 |
134 | Hypertriglyceridemia (HP:0002155) | 1.93411120 |
135 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92182197 |
136 | Bowel incontinence (HP:0002607) | 1.91584923 |
137 | Premature rupture of membranes (HP:0001788) | 1.91341536 |
138 | Cardiovascular calcification (HP:0011915) | 1.90491881 |
139 | Abnormality of iron homeostasis (HP:0011031) | 1.90329933 |
140 | Abnormality of the foot musculature (HP:0001436) | 1.89702177 |
141 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.89231614 |
142 | Subaortic stenosis (HP:0001682) | 1.89231614 |
143 | Opisthotonus (HP:0002179) | 1.88287721 |
144 | Hammertoe (HP:0001765) | 1.88233574 |
145 | Status epilepticus (HP:0002133) | 1.87664073 |
146 | Bronchomalacia (HP:0002780) | 1.86052862 |
147 | Depression (HP:0000716) | 1.83213904 |
148 | Thrombophlebitis (HP:0004418) | 1.83044122 |
149 | * Abnormal cartilage morphology (HP:0002763) | 1.82820038 |
150 | Pointed chin (HP:0000307) | 1.82581282 |
151 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81656783 |
152 | Asymmetric septal hypertrophy (HP:0001670) | 1.81599002 |
153 | Abnormality of the gallbladder (HP:0005264) | 1.80630144 |
154 | Asymmetry of the thorax (HP:0001555) | 1.80532950 |
155 | Ankyloglossia (HP:0010296) | 1.79513145 |
156 | Renovascular hypertension (HP:0100817) | 1.79357049 |
157 | Termporal pattern (HP:0011008) | 1.79346802 |
158 | Insidious onset (HP:0003587) | 1.79346802 |
159 | Scapular winging (HP:0003691) | 1.79029405 |
160 | Myoglobinuria (HP:0002913) | 1.77210282 |
161 | Enlarged kidneys (HP:0000105) | 1.76615356 |
162 | Abnormal large intestine physiology (HP:0012700) | 1.75732180 |
163 | Mitral regurgitation (HP:0001653) | 1.75599240 |
164 | Proximal tubulopathy (HP:0000114) | 1.75517929 |
165 | Reticulocytosis (HP:0001923) | 1.73500274 |
166 | Urinary urgency (HP:0000012) | 1.73336586 |
167 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.72816201 |
168 | Vertebral arch anomaly (HP:0008438) | 1.72147303 |
169 | Gingival bleeding (HP:0000225) | 1.72146683 |
170 | Elfin facies (HP:0004428) | 1.71968906 |
171 | Ulnar deviation of the wrist (HP:0003049) | 1.71790290 |
172 | Stroke (HP:0001297) | 1.71680494 |
173 | Arnold-Chiari malformation (HP:0002308) | 1.71094256 |
174 | Rhabdomyolysis (HP:0003201) | 1.70373814 |
175 | Germ cell neoplasia (HP:0100728) | 1.68807780 |
176 | Long palpebral fissure (HP:0000637) | 1.67775070 |
177 | Flat acetabular roof (HP:0003180) | 1.67185046 |
178 | Ragged-red muscle fibers (HP:0003200) | 1.67008571 |
179 | Thin ribs (HP:0000883) | 1.66961392 |
180 | Athetosis (HP:0002305) | 1.66661141 |
181 | Precocious puberty (HP:0000826) | 1.66383871 |
182 | Hypercalcemia (HP:0003072) | 1.66178322 |
183 | Biconcave vertebral bodies (HP:0004586) | 1.66157712 |
184 | Bulbar palsy (HP:0001283) | 1.66142658 |
185 | Neuronal loss in central nervous system (HP:0002529) | 1.62261174 |
186 | Bundle branch block (HP:0011710) | 1.61352092 |
187 | Bladder diverticulum (HP:0000015) | 1.61059968 |
188 | Peripheral hypomyelination (HP:0007182) | 1.60290851 |
189 | Spastic gait (HP:0002064) | 1.59315729 |
190 | Abnormality of the salivary glands (HP:0010286) | 1.58418775 |
191 | Renal duplication (HP:0000075) | 1.56112981 |
192 | Distal arthrogryposis (HP:0005684) | 1.55270574 |
193 | Distal sensory impairment (HP:0002936) | 1.54624945 |
194 | Advanced eruption of teeth (HP:0006288) | 1.54512158 |
195 | Atrioventricular block (HP:0001678) | 1.53393852 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.21105425 |
2 | SIK1 | 4.46914375 |
3 | TRIB3 | 4.35978418 |
4 | ERN1 | 4.32203721 |
5 | PKN2 | 3.66530610 |
6 | FGFR4 | 3.34168669 |
7 | PRPF4B | 3.32077404 |
8 | SMG1 | 3.30999344 |
9 | PRKD3 | 2.27675898 |
10 | CDK12 | 2.07843518 |
11 | ARAF | 1.99033069 |
12 | FLT3 | 1.93655199 |
13 | TAOK3 | 1.92833330 |
14 | EEF2K | 1.85795664 |
15 | MAP3K10 | 1.78176967 |
16 | ERBB4 | 1.77574006 |
17 | MAP2K4 | 1.74412588 |
18 | PTK6 | 1.74009536 |
19 | PHKG1 | 1.70772015 |
20 | PHKG2 | 1.70772015 |
21 | MAP3K13 | 1.68893152 |
22 | NTRK1 | 1.62120813 |
23 | RIPK1 | 1.57846640 |
24 | LATS2 | 1.39728315 |
25 | MAPK11 | 1.39509172 |
26 | IRAK3 | 1.38027619 |
27 | DAPK2 | 1.37693319 |
28 | PDGFRA | 1.35275397 |
29 | INSRR | 1.31437412 |
30 | GRK6 | 1.28239790 |
31 | MST1R | 1.27184724 |
32 | LATS1 | 1.24313380 |
33 | CAMK1D | 1.22395022 |
34 | PDK3 | 1.19942007 |
35 | PDK4 | 1.19942007 |
36 | LMTK2 | 1.17920359 |
37 | ICK | 1.12360652 |
38 | MARK2 | 1.11535792 |
39 | KSR2 | 1.10296876 |
40 | OBSCN | 1.07155785 |
41 | MAP3K11 | 1.06731175 |
42 | MAP3K7 | 1.05766516 |
43 | BRAF | 1.02875374 |
44 | MAP2K3 | 1.00236727 |
45 | NEK1 | 1.00197600 |
46 | SCYL2 | 0.99989968 |
47 | MOS | 0.99892452 |
48 | PIK3CG | 0.99175112 |
49 | JAK2 | 0.98469064 |
50 | UHMK1 | 0.98468361 |
51 | RET | 0.97208625 |
52 | ABL2 | 0.95896927 |
53 | PTK2 | 0.93590404 |
54 | MAP2K1 | 0.91793782 |
55 | NTRK3 | 0.89780328 |
56 | PRKAA2 | 0.88110536 |
57 | TYK2 | 0.86622306 |
58 | MAPKAPK3 | 0.86107727 |
59 | CDK6 | 0.84853620 |
60 | LRRK2 | 0.84215809 |
61 | MTOR | 0.82634931 |
62 | DDR2 | 0.81010241 |
63 | FGFR2 | 0.78677078 |
64 | MAPK4 | 0.78345752 |
65 | TAOK2 | 0.76904296 |
66 | NTRK2 | 0.76431540 |
67 | NME2 | 0.75359208 |
68 | KDR | 0.73857250 |
69 | BMX | 0.73077030 |
70 | TESK1 | 0.70898181 |
71 | TAOK1 | 0.70490144 |
72 | EPHA4 | 0.70250564 |
73 | SGK3 | 0.69781987 |
74 | ERBB2 | 0.68436272 |
75 | PAK2 | 0.67592400 |
76 | RPS6KA2 | 0.66169167 |
77 | PINK1 | 0.64641743 |
78 | PDPK1 | 0.64580074 |
79 | PRKCZ | 0.63356580 |
80 | DYRK1B | 0.63288317 |
81 | AKT2 | 0.62393703 |
82 | MAPK12 | 0.62189140 |
83 | NEK6 | 0.62019024 |
84 | FGFR1 | 0.61825558 |
85 | PRKAA1 | 0.61457545 |
86 | JAK1 | 0.61011573 |
87 | FGFR3 | 0.60704822 |
88 | SIK2 | 0.60437147 |
89 | TTN | 0.59928716 |
90 | STK38 | 0.59625614 |
91 | CAMK1G | 0.59367363 |
92 | EPHB1 | 0.58237132 |
93 | TBK1 | 0.57882869 |
94 | GSK3A | 0.57851950 |
95 | MET | 0.57787284 |
96 | MAPK10 | 0.56389975 |
97 | ALK | 0.55304350 |
98 | CDK11A | 0.54991440 |
99 | PRKACG | 0.54280722 |
100 | CDK15 | 0.53390981 |
101 | SGK494 | 0.52597274 |
102 | SGK223 | 0.52597274 |
103 | BRD4 | 0.52454866 |
104 | MAP3K3 | 0.50200429 |
105 | MAP3K6 | 0.49391680 |
106 | PAK3 | 0.48584090 |
107 | MAP3K9 | 0.47331781 |
108 | PDK1 | 0.46575234 |
109 | RPS6KB1 | 0.46363708 |
110 | CSF1R | 0.46275209 |
111 | CAMKK1 | 0.45009899 |
112 | CDK4 | 0.44733084 |
113 | CDK18 | 0.44267704 |
114 | CDK5 | 0.43481395 |
115 | RPS6KB2 | 0.43048939 |
116 | PRKCH | 0.42835302 |
117 | RAF1 | 0.42820709 |
118 | PRKD2 | 0.42666244 |
119 | TGFBR1 | 0.41629550 |
120 | MAP3K5 | 0.41478609 |
121 | CDK14 | 0.40955993 |
122 | TYRO3 | 0.40149961 |
123 | FRK | 0.39991377 |
124 | EPHA2 | 0.39453057 |
125 | MAP2K6 | 0.38680647 |
126 | CAMK2G | 0.38148061 |
127 | TGFBR2 | 0.37692221 |
128 | MATK | 0.36500540 |
129 | MAP2K2 | 0.35777112 |
130 | PAK4 | 0.34900479 |
131 | FER | 0.34740612 |
132 | MARK1 | 0.34536241 |
133 | ACVR1B | 0.34421165 |
134 | KSR1 | 0.34375712 |
135 | DAPK1 | 0.34257322 |
136 | PDGFRB | 0.33856994 |
137 | RPS6KA1 | 0.32988926 |
138 | RPS6KC1 | 0.32806605 |
139 | RPS6KL1 | 0.32806605 |
140 | CDK9 | 0.32796592 |
141 | CSK | 0.32612724 |
142 | IRAK2 | 0.32558338 |
143 | MAP3K8 | 0.32550730 |
144 | CDC42BPA | 0.32399923 |
145 | MAP3K2 | 0.31970349 |
146 | IGF1R | 0.29765942 |
147 | DAPK3 | 0.29643550 |
148 | MAP3K1 | 0.28887706 |
149 | PAK6 | 0.28093679 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.19502656 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.72063329 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35660527 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.21892338 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05213837 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.80493600 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.69349874 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.66391299 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65862367 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59118366 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45364556 |
12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.43601596 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.25164366 |
14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.23608620 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.11747962 |
16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.08885479 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.08404639 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.07027425 |
19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.00444788 |
20 | * Peroxisome_Homo sapiens_hsa04146 | 1.95948856 |
21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.78466621 |
22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.73418440 |
23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72488363 |
24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69593882 |
25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67481140 |
26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.65529157 |
27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63923872 |
28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63436934 |
29 | Long-term potentiation_Homo sapiens_hsa04720 | 1.60262360 |
30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58683203 |
31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56393151 |
32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55997968 |
33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54221807 |
34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53383754 |
35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.51688883 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.48868052 |
37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.45060266 |
38 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.44102574 |
39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.43203160 |
40 | Glioma_Homo sapiens_hsa05214 | 1.42968819 |
41 | Endometrial cancer_Homo sapiens_hsa05213 | 1.42962165 |
42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40080599 |
43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39654565 |
44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.37253711 |
45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.35940337 |
46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35483703 |
47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.35370030 |
48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31750444 |
49 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.30835147 |
50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.30560511 |
51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30241039 |
52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27199364 |
53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24272491 |
54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20791692 |
55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.20238990 |
56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.18832310 |
57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18322211 |
58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17290814 |
59 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.17032133 |
60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12156514 |
61 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11856012 |
62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11589376 |
63 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11195255 |
64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09206407 |
65 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08511001 |
66 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08375964 |
67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07455007 |
68 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.02863053 |
69 | ABC transporters_Homo sapiens_hsa02010 | 1.01555217 |
70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97306204 |
71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.97053965 |
72 | Lysine degradation_Homo sapiens_hsa00310 | 0.91594770 |
73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91511128 |
74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.91341985 |
75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90679077 |
76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90311487 |
77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89480912 |
78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89277123 |
79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88955093 |
80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88729050 |
81 | Melanogenesis_Homo sapiens_hsa04916 | 0.87858552 |
82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87483103 |
83 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87296793 |
84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86951102 |
85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.86081482 |
86 | Focal adhesion_Homo sapiens_hsa04510 | 0.84800852 |
87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84357222 |
88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83698599 |
89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.82437216 |
90 | Adherens junction_Homo sapiens_hsa04520 | 0.80927020 |
91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79289155 |
92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77559059 |
93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76503648 |
94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.76176997 |
95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75997301 |
96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74863434 |
97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74235003 |
98 | Gap junction_Homo sapiens_hsa04540 | 0.73111904 |
99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72902494 |
100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69964930 |
101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68910661 |
102 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67586503 |
103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67547439 |
104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66776120 |
105 | Prostate cancer_Homo sapiens_hsa05215 | 0.66270738 |
106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65590349 |
107 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.64500598 |
108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61651400 |
109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60097907 |
110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59796327 |
111 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58815437 |
112 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58578975 |
113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58530839 |
114 | Tight junction_Homo sapiens_hsa04530 | 0.58435067 |
115 | Axon guidance_Homo sapiens_hsa04360 | 0.58256991 |
116 | Insulin secretion_Homo sapiens_hsa04911 | 0.57985896 |
117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57891865 |
118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57193921 |
119 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.56686370 |
120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55818257 |
121 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.55164169 |
122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54900625 |
123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52746163 |
124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52646541 |
125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46562430 |
126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45804423 |
127 | Insulin resistance_Homo sapiens_hsa04931 | 0.44525248 |
128 | Prion diseases_Homo sapiens_hsa05020 | 0.43427749 |
129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43396737 |
130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38140321 |
131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33470757 |
132 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29635677 |
133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28653056 |
134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.18445578 |
135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17783690 |
136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17395709 |
137 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.07947297 |
138 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.06100880 |
139 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03429288 |
140 | Bladder cancer_Homo sapiens_hsa05219 | 0.03153496 |
141 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.03124445 |
142 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00910474 |
143 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.1784341 |
144 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1650868 |
145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1554553 |
146 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.1482605 |
147 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1342357 |
148 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1202741 |
149 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.1132554 |
150 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1075868 |
151 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1048347 |
152 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1019087 |
153 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0997664 |
154 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0995116 |
155 | Amoebiasis_Homo sapiens_hsa05146 | -0.0860712 |
156 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0362303 |
157 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0104752 |
158 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0020379 |